+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cancer Immunotherapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

  • ID: 5562605
  • Report
  • March 2022
  • Region: Global
  • 143 Pages
  • IMARC Group
The global cancer immunotherapy market reached a value of US$ 96.6 Billion in 2021. Looking forward, the publisher expects the market to reach a value of US$ 167.5 Billion by 2027 exhibiting a CAGR of 9.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.



Cancer is a preventable disease starting in any organ or tissue of the body on account of the abnormal cell growth that invades adjoining parts of the body and spreads to other organs. It is one of the leading causes of death globally, which is nowadays treated using cancer immunotherapy. Cancer immunotherapy offers more advantages than conventional anti-tumor therapy that can prolong progression-free survival (PFS) and overall survival (OS). It can be combined with radiation, chemotherapy, surgery, or targeted therapies to improve their effectiveness. Apart from this, as it enables the immune system to recognize, prevent, control, and eliminate cancer, cancer immunotherapy finds extensive applications in hospitals, cancer research centers, and clinics around the world.

Cancer Immunotherapy Industry Trends and Drivers:

There is currently an increase in the number of people who have cancer across the globe. This, in confluence with the burgeoning healthcare industry, represents one of the key factors propelling the growth of the market. Moreover, there are fewer side effects associated with cancer immunotherapy. As a result, there is a significant rise in the use of monoclonal antibodies to treat different types of cancer by selectively attacking cancerous cells. This, coupled with the rising prevalence of multiple myeloma and melanoma, is catalyzing the demand for cancer immunotherapy. Besides this, leading players are sponsoring patient assistance programs (PAPs) that provide financial assistance to low-income individuals for augmenting the existing prescription drug coverage. This, in turn, is positively influencing the market. Other factors strengthening the growth of the market are technological advancements in clinical therapies, extensive research and development (R&D) activities, and the introduction of advanced variants with enhanced efficacy and effectiveness of treatment.

Key Market Segmentation:


The publisher provides an analysis of the key trends in each sub-segment of the global cancer immunotherapy market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on therapy type, application and end user.

Breakup by Therapy Type:

  • Monoclonal Antibodies
  • Cancer Vaccines
  • Checkpoint Inhibitors
  • Immunomodulators
  • Others

Breakup by Application:

  • Lung Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Melanoma
  • Prostate Cancer
  • Head and Neck Cancer
  • Others

Breakup by End User:

  • Hospitals
  • Cancer Research Centers
  • Clinics
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:


The competitive landscape of the industry has also been examined along with the profiles of the key players being Amgen Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck KGAA, Novartis AG, Pfizer Inc., Sanofi, and Seagen Inc.

Key Questions Answered in This Report:


  • How has the global cancer immunotherapy market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global cancer immunotherapy market?
  • What are the key regional markets?
  • What is the breakup of the market based on the therapy type?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global cancer immunotherapy market and who are the key players?
  • What is the degree of competition in the industry?
Frequently Asked Questions about the Global Cancer Immunotherapy Market

What is the estimated value of the Global Cancer Immunotherapy Market?

The Global Cancer Immunotherapy Market was estimated to be valued at $96.6 Billion in 2021.

What is the growth rate of the Global Cancer Immunotherapy Market?

The growth rate of the Global Cancer Immunotherapy Market is 9.6%, with an estimated value of $167.5 Billion by 2027.

What is the forecasted size of the Global Cancer Immunotherapy Market?

The Global Cancer Immunotherapy Market is estimated to be worth $167.5 Billion by 2027.

Who are the key companies in the Global Cancer Immunotherapy Market?

Key companies in the Global Cancer Immunotherapy Market include Amgen Inc., AstraZeneca plc, Bayer AG, Bristol, Myers Squibb Company, Eli Lilly, Company, F. Hoffmann and GlaxoSmithKline Plc.

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Cancer Immunotherapy Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Therapy Type
6.1 Monoclonal Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Cancer Vaccines
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Checkpoint Inhibitors
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Immunomodulators
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Application
7.1 Lung Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Breast Cancer
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Colorectal Cancer
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Melanoma
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Prostate Cancer
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Head and Neck Cancer
7.6.1 Market Trends
7.6.2 Market Forecast
7.7 Others
7.7.1 Market Trends
7.7.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cancer Research Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Clinics
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Others
8.4.1 Market Trends
8.4.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Amgen Inc.
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AstraZeneca plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bayer AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Bristol-Myers Squibb Company
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Eli Lilly and Company
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 F. Hoffmann-La Roche AG
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 SWOT Analysis
14.3.7 GlaxoSmithKline Plc
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Johnson & Johnson
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Merck KGAA
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Novartis AG
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Pfizer Inc.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Sanofi
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Seagen Inc.
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Cancer Immunotherapy Market: Major Drivers and Challenges
Figure 2: Global: Cancer Immunotherapy Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Cancer Immunotherapy Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Cancer Immunotherapy Market: Breakup by Therapy Type (in %), 2021
Figure 5: Global: Cancer Immunotherapy Market: Breakup by Application (in %), 2021
Figure 6: Global: Cancer Immunotherapy Market: Breakup by End User (in %), 2021
Figure 7: Global: Cancer Immunotherapy Market: Breakup by Region (in %), 2021
Figure 8: Global: Cancer Immunotherapy (Monoclonal Antibodies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Cancer Immunotherapy (Monoclonal Antibodies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Cancer Immunotherapy (Cancer Vaccines) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Cancer Immunotherapy (Cancer Vaccines) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Cancer Immunotherapy (Checkpoint Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Cancer Immunotherapy (Checkpoint Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Cancer Immunotherapy (Immunomodulators) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Cancer Immunotherapy (Immunomodulators) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Cancer Immunotherapy (Other Therapy Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Cancer Immunotherapy (Other Therapy Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Cancer Immunotherapy (Lung Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Cancer Immunotherapy (Lung Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Cancer Immunotherapy (Breast Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Cancer Immunotherapy (Breast Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Cancer Immunotherapy (Colorectal Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Cancer Immunotherapy (Colorectal Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Cancer Immunotherapy (Melanoma) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Cancer Immunotherapy (Melanoma) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Cancer Immunotherapy (Prostate Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Cancer Immunotherapy (Prostate Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Cancer Immunotherapy (Head and Neck Cancer) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Cancer Immunotherapy (Head and Neck Cancer) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Cancer Immunotherapy (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Cancer Immunotherapy (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Cancer Immunotherapy (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Cancer Immunotherapy (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Cancer Immunotherapy (Cancer Research Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Cancer Immunotherapy (Cancer Research Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Cancer Immunotherapy (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Cancer Immunotherapy (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Cancer Immunotherapy (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Cancer Immunotherapy (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: North America: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: North America: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: United States: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: United States: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Canada: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Canada: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Asia-Pacific: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Asia-Pacific: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: China: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: China: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Japan: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Japan: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: India: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: India: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: South Korea: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: South Korea: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Australia: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Australia: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Indonesia: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Indonesia: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Others: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Europe: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Europe: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Germany: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Germany: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: France: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: France: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: United Kingdom: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: United Kingdom: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Italy: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Italy: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Spain: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Spain: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Russia: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Russia: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Others: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Latin America: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Latin America: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Brazil: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Brazil: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Mexico: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Mexico: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 84: Others: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 85: Others: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 86: Middle East and Africa: Cancer Immunotherapy Market: Sales Value (in Million US$), 2016 & 2021
Figure 87: Middle East and Africa: Cancer Immunotherapy Market: Breakup by Country (in %), 2021
Figure 88: Middle East and Africa: Cancer Immunotherapy Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 89: Global: Cancer Immunotherapy Industry: SWOT Analysis
Figure 90: Global: Cancer Immunotherapy Industry: Value Chain Analysis
Figure 91: Global: Cancer Immunotherapy Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Cancer Immunotherapy Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cancer Immunotherapy Market Forecast: Breakup by Therapy Type (in Million US$), 2022-2027
Table 3: Global: Cancer Immunotherapy Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 4: Global: Cancer Immunotherapy Market Forecast: Breakup by End User (in Million US$), 2022-2027
Table 5: Global: Cancer Immunotherapy Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Cancer Immunotherapy Market: Competitive Structure
Table 7: Global: Cancer Immunotherapy Market: Key Players

Companies Mentioned

  • Amgen Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Eli Lilly
  • Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck KGAA
  • Novartis AG
  • Pfizer Inc.
  • Sanofi
  • Seagen Inc.

Methodology

Loading
LOADING...